top of page

Guadalupe Hayes-Mota

Wesite Page Pic.png

Guadalupe
Hayes-Mota

Advocate for patients to have access to medicines and health services globally

Healthcare, Biotech, & Public Service Leader:

Story

Story

Born in Mexico with a rare and debilitating bleeding disorder, Guadalupe nearly died at twelve because of limited access to medicines. One night, his appendix burst, and he began bleeding internally, requiring emergency surgery. In search of better medication to stop the bleeding, Guadalupe was rushed to a hospital eight hours away. He bled so severely during the surgery that his heart stopped beating, and the doctors declared him clinically dead. But against all odds, Guadalupe survived.

After his recovery, his family and he migrated to the U.S., searching for better healthcare for him. The transition was difficult: his parents arrived in California with little money or education, and Guadalupe spoke no English. Navigating the health care system as an immigrant and not knowing the language was a challenge. Accessing treatment and services for his disease was practically impossible at first. The nearest specialist was one hr and a half away. Thankfully, he gained access to care and treatment with help from the Hemophilia Association chapter in the area. Driven by his experiences, Guadalupe made it his mission to fight for justice and equity in the healthcare system.

Guadalupe Hayes-Mota

Guadalupe Hayes-Mota

Play Video

Video: Guadalupe speaks about growing up with hemophilia in Mexico without medicines.

Professional Experience

Experience

Mission..............................

Guadalupe envisions a world where medical care isn't a privilege, but a right. Drawing strength from his own life on the fringes, he stands for justice and equity. He's not just a voice, but a driving force, igniting change and innovation across healthcare, from biopharmaceuticals to non-profits.

Guadalupe Hayes-Mota Picture in Memorial Drive

Professional Experience.........

Drawing from vast healthcare expertise, Guadalupe is a serial entrepreneur. Currently, he is the CEO & Co-Founder of a Stealth AI Healthcare Startup. Previously, Guadalupe founded and led as CEO of Healr Solutions, a tech pioneer addressing critical biopharmaceutical supply chain challenges, impacting 43 countries. Venture got acquired by major investors. He's steered global divisions of powerhouse firms like Ultragenyx, Biogen, Amgen, and GSK as Senior Vice-President and Chief Supply Chain Officer, and he ensured medicine reached 2.3 billion people across 113 countries.

Under his leadership, UCLA Health became the largest free healthcare provider in the U.S., serving 30,000 underserved individuals. A key contributor to the Affordable Care Act, he helped extend healthcare to 20 million Americans while at the RAND Corporation. Beyond boardrooms, Guadalupe has also collaborated on groundbreaking drug research at MIT with Moderna's founder, Professor Bob Langer.

Public Service & Boards.........

Appointed by Governor Charlie Baker to the Massachusetts Rare Disease Advisory Council, Guadalupe shapes state policy on rare diseases, guiding key decision-makers from the governor's office to the public health department.

A recognized healthcare authority, he's been featured in high-profile outlets such as Forbes, Inc., Fast Company, MarketWatch, Boston Globe, MIT Technology Review and has lent his voice to esteemed platforms at the National Academy of Engineering, MIT, Harvard, and UPenn, even testifying before the U.S. Congress.

An advocate for diversity and community, Guadalupe re-established and presided over the MIT LGBT+ Alumni Association. He has sat on multiple boards including AI 2030, Save One Life, MIT Alumni Association, and Fenway Health. He serves as an Advisory Board Member for Sanofi, a Fortune 500 biopharmaceutical, a Forbes Business Council Member, and a Fast Company Impact Council Member.

Guadalupe Hayes-Mota lecturing at MIT a class on bioengineering and medicine

Education............................

Guadalupe Hayes-Mota delivering a keynote speech at MIT

Guadalupe received a BS in Chemistry, an MS in AI Engineering Systems, and an MBA from MIT. He obtained a Master of Public Policy from Georgetown University, and a Master of Public Administration from Harvard University.

Honors................................

6 Powerful LGBTQ+ Executives - Business Insider
US Young Engineering Leader - National Academy of Engineering
John F. Kennedy Fellowship - Harvard University
Notable Alum - MIT
100 Top Leaders in the Life Science Industry - PharmaVoice
40 under 40 - Boston Business Journal
Healthcare Executive of the Year - Los Angeles Business Journal

Community Leadership

Public Service

Guadalupe Hayes-Mota Treasurer and Finance Committee Chair in the Board of Directors

Fenway Health
Finance Committee Chair,
Board of Directors

Delivers inclusive health care and support to LGBTQIA+, BIPOC, and underserved groups, focusing on transformative research and education for global impact

Guadalupe Hayes-Mota appointed to the Massachusetts Rare Disease Advisory Council

Rare Disease Advisory Council
Council Member

Appointed by Governor Baker to provide advice to the Governor, Senate, House of Representatives, and Department of Public Health on how to address rare disease policy and actions in Massachusetts

Guadalupe Hayes-Mota served in the Board of Directors of Save One Life

Save One Life
Strategic Committee Chair,
Board of Directors

Empowers individuals and families affected by bleeding disorders in developing countries through direct financial assistance and access to medical treatment.

Guadalupe Hayes-Mota Board of Directors of the MIT Alumni Association

MIT Alumni Association
Board of Directors

Empower MIT alumni to contribute to a better world, fostering mutual engagement and support within the global MIT community

Teaching

Teaching

Teacher/ Mentor of the Next Generation of STEM Entrepreneurs Leaders

Guadalupe Hayes-Mota teaching at MIT

Guadalupe Hayes-Mota is a Senior Lecturer at MIT

Senior Lecturer and Practitioner in Residence - MIT

Guadalupe Hayes-Mota teaches ethics of biopharmaceuticals, global operations, and leadership in healthcare organizations.

Press

In The News

Press

Guadalupe Hayes-Mota published in the Boston Globe

Guadalupe Hayes-Mota presenting results of Healr Solutions at the National Academy of Engineering

Guadalupe Hayes-Mota published in the MIT Technology Review

Guadalupe Hayes-Mota written in Rare Revolution Magazine

Guadalupe Hayes-Mota recognized as 40 under 40 by the Boston Business Journal

Guadalupe Hayes-Mota named Pharmavoice 100 Most Inspiring Leader

Publications

Publications

Five Areas Where AI Is Revolutionizing The Biopharmaceutical Industry

by Guadalupe Hayes-Mota

With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping researchers speed up drug discovery, improve the clinical trial design and further personalize patient treatment.

Here are five areas where I see AI and machine learning changing the biopharmaceutical industry.

Shaping A Responsible AI-Powered Future In Life Science

by Guadalupe Hayes-Mota

The unprecedented power of artificial intelligence (AI) is transforming the life sciences industry, opening doors to groundbreaking drug discoveries, innovative treatments and the promise of personalized medicine. As we harness AI's potential, addressing the ethical challenges that arise is imperative. This article outlines a new, robust ethical framework to ensure that AI serves humanity's best interests.

I’m a biopharma supply chain specialist — and even I can’t find the Adderall I’m prescribed

by Guadalupe Hayes-Mota

For 10 years, I have depended on Adderall to help me function. But in February, for the first time, the pharmacy down the street was unable to fill my prescription. In fact, 19 pharmacies in a row told me that they were out of stock. Thankfully, the 20th was able to fill it — though it meant a 50-minute drive.

15 Tips For Identifying And Addressing Operational Inefficiencies

by Guadalupe Hayes-Mota

Every organization faces operational inefficiencies that can impede productivity, hinder growth and waste resources. As a leader, it's your responsibility to identify these inefficiencies and streamline processes to make your organization more efficient and effective. However, identifying the biggest operational inefficiencies can be a challenge, especially if you don't know where to look.

21 states give rare disease patients a seat at the table. The other 29 need to follow suit

by Guadalupe Hayes-Mota

A powerful movement is taking shape in the U.S. rare disease community that could transform the lives of millions of people. That’s right — millions. Even though a single rare disease may affect only a few individuals, there are several thousand of these problematic diseases that are difficult to identify and treat.

Since 2015, 21 U.S. states have passed legislation to create Rare Disease Advisory Councils that provide platforms for patients and family members to communicate with experts, policymakers, and the broader public.

How Managers And Leaders Can Actively Support Individuals With Invisible Disabilities

by Guadalupe Hayes-Mota

Invisible disabilities, as the name suggests, are disabilities that are not immediately apparent to others. Out of the 61 million adults in the United States who identify as having a disability of some kind, roughly 10% of those are invisible disabilities, which may include cognitive, neurological or mental health challenges.

I provide healthcare policy advice to Congress regarding disability policies, have led organizations that cater to individuals with disabilities and also have a disability myself.

Creating A Connected Supply Chain With Higher Visibility In The Biopharmaceutical Industry

by Guadalupe Hayes-Mota

The biopharmaceutical industry, valued at over $350 billion, is a cornerstone of global health innovation. The onset of the Covid-19 pandemic highlighted the industry's importance and the need for transparent, agile and connected supply chains. This article delves into strategies to enhance supply chain visibility in biopharma.

7 Strategies For Biopharmaceutical Company Fundraising

by Guadalupe Hayes-Mota

Launching a biopharmaceutical company requires groundbreaking scientific research and substantial financial resources. At the same time, securing funding may seem daunting, but various strategies and ideas can greatly enhance your chances of successfully raising capital.

As a founder and CEO of a startup and someone who has worked in fundraising, here are some valuable tips and innovative approaches to fundraising for biopharmaceutical startups.

Speaking Arrangement

PIA Puerto Rico.jpg

Keynote Speaker (Pharmaceutical Industry Association of Puerto Rico): Guadalupe discusses how to create access to medicines to patients worlwide

Guadalupe Hayes-Mota teaches pharmaceutical supply chains

Podcast (McSquare Health Podcast): COVID-19's Effects on Drug Discovery and Delivery.

Webinar (MIT Alumni Association): Connecting Communities - A Conversation on Race, LBGTQ+ Identity and STEM.

Speaking Engagements

Keynote Speaker (National Academy of Engineering): Guadalupe explores the technology needed to create connected supply chain in the biopharmaceutical world.

Guadalupe Hayes-Mota talking about being a public service leader in one communnity

Presentation (MIT Tech Reunions): Guadalupe reflects on the impact he is having in global and local communities through board of directors service and governmental appointments.

Guadalupe Hayes-Mota presentation of the Industrial Internet of Things Insights at a conference

Presentation (Biomanufacturing and Cell and Gene Therapy Strategy Meeting): Guadalupe presents about Internet of Things (IIoT) insights and knowledge to minimize waste within manufacturing systems.

Keynote Speaker (MIT Introduction to Technology, Engineering and Science): Guadalupe talks about his struggles with hemophilia in Mexico, , going to MIT, learning and finding purpose.

Keynote Presentation (Clinical Trials Summit): Guadalupe talks about how to manage Clinical Global Supply Chains during COVID-19 times.

Webinar (New York City Hemophilia Chapter and New England Hemophilia Association): Guadalupe explores, in Spanish, advocacy in the Latino community and also about his life as a hemophiliac.

Contact

bottom of page